Literature DB >> 18368555

Role of hormonal and other factors in human prostate cancer.

Donald T Wigle1, Michelle C Turner, James Gomes, Marie-Elise Parent.   

Abstract

American men have a lifetime risk of about 18% for prostate cancer diagnosis. Large international variations in prostate cancer risks and increased risks among migrants from low- to high-risk countries indicate important roles for environmental factors. Major known risk factors include age, family history, and country/ethnicity. Type 2 diabetes appears to reduce risk, while high birth weight and adult height are linked to increased risk of aggressive prostate cancer. Limited evidence supports an association with a history of sexually transmitted infections. A previous meta-analysis of eight cohort studies indicated no associations with plasma androgen, estrogen, or sex hormone binding globulin (SHBG) levels. However, there were dose-response relationships with baseline plasma testosterone levels in two studies that adjusted for other serum hormones and obesity. Finasteride (a drug that blocks testosterone activation) reduced prostate cancer risk by 25%. Low-frequency genes linked to familial prostate cancer only explain a small fraction of all cases. Sporadic cases were linked to relatively common polymorphisms of genes involved in (1) androgen synthesis, activation, inactivation and excretion, (2) hormone and vitamin D receptors, (3) carcinogen metabolism, and (4) DNA repair. Epidemiologic evidence supports protective roles for dietary selenium, vitamin E, pulses, tomatoes/lycopene, and soy foods, and high plasma 1,25-dihydroxyvitamin D levels. There is inadequate evidence that vegetables, fruit, carotenoids, and vitamins A and C reduce risk and that animal fat, alpha-linoleic acid, meat, coffee, and tea increase risk. Two major cohort studies found dose-response relationships with dietary calcium intake. Total dietary energy intake may enhance risk. Limited evidence supports a protective role for physical activity and elevated risk for farmers and other men with occupational pesticide exposure, particularly to organochlorine compounds and phenoxy herbicides. There is inadequate evidence for a relationship with alcohol or smoking. Most known or suspected external risk factors may act through hormonal mechanisms, but our review found little supporting evidence, and substantial further research is needed.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18368555     DOI: 10.1080/10937400701873548

Source DB:  PubMed          Journal:  J Toxicol Environ Health B Crit Rev        ISSN: 1093-7404            Impact factor:   6.393


  10 in total

1.  Null activity of selenium and vitamin e as cancer chemopreventive agents in the rat prostate.

Authors:  David L McCormick; K V N Rao; William D Johnson; Maarten C Bosland; Ronald A Lubet; Vernon E Steele
Journal:  Cancer Prev Res (Phila)       Date:  2010-02-09

2.  Prenatal exposure to ethinylestradiol alters the morphologic patterns and increases the predisposition for prostatic lesions in male and female gerbils during ageing.

Authors:  Ana P S Perez; Manoel F Biancardi; Cássia R S Caires; Luiz R Falleiros-Junior; Rejane M Góes; Patricia S L Vilamaior; Fernanda C A Santos; Sebastião R Taboga
Journal:  Int J Exp Pathol       Date:  2016-02-08       Impact factor: 1.925

3.  Estrogen receptor alpha gene polymorphisms and risk of prostate cancer: a meta-analysis involving 18 studies.

Authors:  Zhenwei Gu; Gang Wang; Weiguo Chen
Journal:  Tumour Biol       Date:  2014-03-01

Review 4.  Estrogen receptors in gastric cancer: Advances and perspectives.

Authors:  Muhammad Saif Ur Rahman; Jiang Cao
Journal:  World J Gastroenterol       Date:  2016-02-28       Impact factor: 5.742

5.  Dioscin-induced apoptosis of human LNCaP prostate carcinoma cells through activation of caspase-3 and modulation of Bcl-2 protein family.

Authors:  Jing Chen; Hui-Min Li; Xue-Nong Zhang; Chao-Mei Xiong; Jin-Lan Ruan
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2014-02-06

6.  Risk of cancer following hospitalization for type 2 diabetes.

Authors:  Kari Hemminki; Xinjun Li; Jan Sundquist; Kristina Sundquist
Journal:  Oncologist       Date:  2010-05-17

Review 7.  Metabolic syndrome, endocrine disruptors and prostate cancer associations: biochemical and pathophysiological evidences.

Authors:  Vincenzo Quagliariello; Sabrina Rossetti; Carla Cavaliere; Rossella Di Palo; Elvira Lamantia; Luigi Castaldo; Flavia Nocerino; Gianluca Ametrano; Francesca Cappuccio; Gabriella Malzone; Micaela Montanari; Daniela Vanacore; Francesco Jacopo Romano; Raffaele Piscitelli; Gelsomina Iovane; Maria Filomena Pepe; Massimiliano Berretta; Carmine D'Aniello; Sisto Perdonà; Paolo Muto; Gerardo Botti; Gennaro Ciliberto; Bianca Maria Veneziani; Francesco De Falco; Piera Maiolino; Michele Caraglia; Maurizio Montella; Rosario Vincenzo Iaffaioli; Gaetano Facchini
Journal:  Oncotarget       Date:  2017-05-02

8.  Does exposure to agricultural chemicals increase the risk of prostate cancer among farmers?

Authors:  Marie-Elise Parent; Marie Désy; Jack Siemiatycki
Journal:  Mcgill J Med       Date:  2009-01

9.  Timing of supplementation of selenium and isoflavones determines prostate cancer risk factor reduction in rats.

Authors:  Jessica R Tolman; Edwin D Lephart; Kenneth Dr Setchell; Dennis L Eggett; Merrill J Christensen
Journal:  Nutr Metab (Lond)       Date:  2008-11-10       Impact factor: 4.169

10.  Epidemiological study of prostate cancer (EPICAP): a population-based case-control study in France.

Authors:  Florence Menegaux; Antoinette Anger; Hasina Randrianasolo; Claire Mulot; Pierre Laurent-Puig; François Iborra; Jean-Pierre Bringer; Benoit Leizour; Rodolphe Thuret; Pierre-Jean Lamy; Xavier Rébillard; Brigitte Trétarre
Journal:  BMC Cancer       Date:  2014-02-19       Impact factor: 4.430

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.